2023
DOI: 10.1016/s2666-6367(23)00317-2
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the Prognostic Utility of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) in Children and Young Adults with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL) Prior to CAR T-Cell Therapy

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles